Erectile dysfunction in patients of diabetes mellitus: a cross sectional study

Authors

  • Anilkumar Bellad Department of General Surgery, J.N. Medical College, KAHER, Belgaum, Karnataka, India
  • Kartik Sahu Department of General Surgery, J.N. Medical College, KAHER, Belgaum, Karnataka, India

DOI:

https://doi.org/10.18203/2349-2902.isj20193165

Keywords:

Diabetes mellitus, Erectile dysfunction, Hypogonadism

Abstract

Background: One of the independent risk factor for erectile dysfunction is diabetes mellitus. The present study planned to determine the prevalence and factors associated with ED in DM.

Methods: A one year cross-sectional study on a total of 208 patients with type 1 or 2 diabetes. National Institutes of Health (NIH) approved questionnaire for International Index of Erectile Function (IIEF) was used to interview each patient to assess for ED.

Results: In this study 12.98% of patients had ED score between 13 to 18 suggestive of mild to moderate ED and 9.62% with 19 to 24 scores suggestive of mild degree. The prevalence of erectile dysfunction was 32.21%. The mean age in patients with erectile dysfunction was significantly high (58.40±10.96 years) compared to those without erectile dysfunction (51.00±11.16 years) (p<0.001) Of the 119 patients with duration of diabetes between one to five years 42.02% had ED and of the 3 patients with duration of more than five years 66.67% had ED (p<0.001). Prevalence of ED was higher in patients with HbA1c levels between 7.0 to 8.5 (32.76%) and >8.5 (37.07%). Prevalence of erectile dysfunction was higher in patients with history of smoking (63.64%) (p<0.001) and alcohol intake (51.85%) (p<0.001). The prevalence of erectile dysfunction was also significantly high in patients with history of hypertension (59.7%) (p<0.001).

Conclusions: The ED in patients with diabetes mellitus was significantly prevalent with age, duration of diabetes, history of hypertension, cardiovascular disease, glycemic control and hypertriglyceridemia.

References

Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res. 2002;14(4):245-50.

Marwat MA, Ali L, Usman M. Erectile Dysfunction in Diabetic Males. Available at: http://apims.net/ Volumes/Vol5-2/Mumtaz%20Ali%20SheikhVol5-2.htm. Accessed on 22 April 2013.

Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50-6.

Fauci AS, Kasper DS, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al. Harrison’s principles of internal medicine. United States; McGraw Hill: 2008.

American Diabetes Association. Clinical practice recommendations 2007. Diabetes Care. 2007;30:4.

U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011.

Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, Joly E, et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci USA. 2005;102(13):4807-12.

Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004;328(7443):807-10.

Tripathy BB, Chandalia HB. RSSDI: Textbook of diabetes mellitus. 2nd ed. New Delhi: Jaypee Brothers; 2008.

Zonszein J. Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am. 1995;22:789-802.

Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am. 1996;25:379-400.

Bortolotti A, Parazzini F, Colli E, Landolini M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl. 1997;20:323-34.

Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Uro. 1999;161:5-11.

Maggi M, Filippi S, Ledda F, Mangini A, Forti G. Erectile dysfunction from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol. 2000;143:143-54.

Sullivan ME, Keoghane SR, Miller MAW. Vascular risk factors and erectile dysfunction. BJU Int. 2001;87:838-45.

Chitaley K, Kupelian V, Subak L, Wessells H. Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol. 2009;182(6 Suppl):S45-50

Fedele D, Coscelli C, Santeusanio F. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care. 1998;21:1973.

Klein R, Klein BE, Moss SE. Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes. J Diabetes Compl. 2005;19:35.

Saigal CS, Wessells H, Pace J. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166:207.

Bacon CG, Hu FB, Giovannucci E. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25:1458.

Johannes CB, Araujo AB, Feldman HA. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol. 2000;163:460.

Chitaley K, Kupelian V, Subak L, Wessells H. Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol 2009;182(6 Suppl):S45-50

El-Sakka AI, Sayed HM, Tayeb KA. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl. 2008;31:602.

Corona G, Mannucci E, Petrone L. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med. 2007;4:1038.

Kapoor D, Clarke S, Channer KS. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl. 2007;30:500.

Corona G, Mannucci E, Petrone L. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006;18:190.

Glina S, Sharlip ID, Hellstrom WJ. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med. 2013;10(1):115-9.

Kim ED. Erectile dysfunction. Available at: http://misc.medscape.com/pi/iphone/medscapeapp/html/A444220-business.html Accessed on 15 August 2013.

Wessells H, Penson DF, Cleary P. Prevalence and predictors of sexual dysfunction in men with type 1 diabetes enrolled in DCCT/EDIC; Presented at annual meeting of American Diabetes Association; San Diego, California, 2005.

William KBA, Owiredu, Nafiu A, Huseini A, Charity S, Christian KG. Determinants of sexual dysfunction among clinically diagnosed diabetic patients: Reproductive Biol Endocrinol. 2011;9:70.

Ali L, Nasir O, Rehman A, Malik A. Off label use of Selective Serotonin Reuptake Inhibitors (SSRIs) in Premature Ejaculation. are they Effective? Ann Pak Inst Med Sci. 2008;4(3):144-7.

Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 1995;22:699-709.

Meena BL, Kochar DK, Agarwal TD, Choudhary R, Kochar A. Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease. Int J Diabetes Dev Ctries. 2009;29(4):150-4.

Ayta IA, McKinlay JM, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Br J Urol Int. 1999;84(1):50-6.

Kloner RA. Assessment of cardiovascular risk in patients with erectile dysfunction: Focus on the diabetic patients. Endrocrine. 2004;23:125–9.

Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator. 2009;22(1&2):1-18.

Giuliano FA, Leriche A, Jaudinot EO, deGendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004;64:1196-201.

Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):204-9.

Wing RR, Rosen RC, Fava JL, Bahnson J, Brancati F, Gendrano IN, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the look AHEAD trial. J Sex Med. 2009;6:1414–22.

Lu CC, Jiann BP, Sun CC, Lam HC, Chu CH, Lee JK. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2009;6:1719–28.

Downloads

Published

2019-07-25

Issue

Section

Original Research Articles